Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.74% |
| 2 | Healthcare | 11.91% |
| 3 | Technology | 7.43% |
| 4 | Financials | 6.52% |
| 5 | Consumer Discretionary | 5.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTHX
2176
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.51M | ﹤0.01% |
137,024
-31,030
| -18% | -$579K |
|
2177
Medifast
MED
$136M
| $1.51M | ﹤0.01% |
24,147
-95,435
| -80% | -$8.69M |
|
2178
Glaukos
GKOS
$10.7B
| $1.51M | ﹤0.01% |
48,880
-416,172
| -89% | -$21.4M |
|
2179
CALL
Ford
F
$55.6B
| $1.51M | ﹤0.01% |
311,800
+235,500
| +309% | +$1.77M |
|
2180
Colgate-Palmolive
CL
$72.5B
| $1.5M | ﹤0.01% |
22,655
-14,684
| -39% | -$1.04M |
|
2181
Algonquin Power & Utilities
AQN
$4.37B
| $1.5M | ﹤0.01% |
112,107
-849,448
| -88% | -$12.4M |
|
|
AAMI
2182
Acadian Asset Management
AAMI
$3.45B
| $1.5M | ﹤0.01% |
235,090
-280,937
| -54% | -$2.43M |
|
|
CSII
2183
DELISTED
Cardiovascular Systems, Inc.
CSII
| $1.5M | ﹤0.01% |
42,564
-63,217
| -60% | -$2.66M |
|
|
PCSB
2184
DELISTED
PCSB Financial Corporation
PCSB
| $1.5M | ﹤0.01% |
107,088
+24,105
| +29% | +$434K |
|
|
RDUS
2185
DELISTED
Radius Health, Inc.
RDUS
| $1.5M | ﹤0.01% |
115,083
-146,280
| -56% | -$2.61M |
|
2186
State Street Industrial Select Sector SPDR ETF
XLI
$33.2B
| $1.49M | ﹤0.01% |
25,292
-148,326
| -85% | -$11.2M |
|
2187
Columbia Banking Systems
COLB
$8.68B
| $1.49M | ﹤0.01% |
55,580
+37,405
| +206% | +$1.31M |
|
|
VTIQW
2188
CALL
DELISTED
VectoIQ Acquisition Corp. Warrant
VTIQW
| $1.49M | ﹤0.01% |
+140,000
| New | +$208K |
|
|
BAND
2189
Bandwidth Inc
BAND
$1.67B
| $1.49M | ﹤0.01% |
+22,128
| New | +$1.51M |
|
|
VMRK
2190
Vivmark Residential
VMRK
$26.1B
| $1.49M | ﹤0.01% |
24,102
-152,682
| -86% | -$11.8M |
|
2191
SiriusPoint
SPNT
$2.8B
| $1.48M | ﹤0.01% |
200,334
-235,151
| -54% | -$2.26M |
|
2192
Weis Markets
WMK
$1.74B
| $1.48M | ﹤0.01% |
35,588
+3,483
| +11% | +$133K |
|
|
SPWR
2193
DELISTED
SunPower Corporation Common Stock
SPWR
| $1.48M | ﹤0.01% |
446,538
+405,001
| +975% | +$2.13M |
|
|
HZNP
2194
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.48M | ﹤0.01% |
+50,000
| New | +$1.69M |
|
2195
Dianthus Therapeutics
DNTH
$6.24B
| $1.48M | ﹤0.01% |
14,703
+6,893
| +88% | +$1.28M |
|
2196
CALL
Conagra Brands
CAG
$7.69B
| $1.48M | ﹤0.01% |
50,300
+32,700
| +186% | +$986K |
|
2197
ArcBest
ARCB
$3.11B
| $1.48M | ﹤0.01% |
84,164
+64,856
| +336% | +$1.49M |
|
2198
Stereotaxis
STXS
$147M
| $1.48M | ﹤0.01% |
488,300
+233,438
| +92% | +$965K |
|
2199
CoStar Group
CSGP
$12.7B
| $1.47M | ﹤0.01% |
25,110
+12,570
| +100% | +$819K |
|
|
SAQNW
2200
CALL
DELISTED
Software Acquisition Group Inc. Warrant
SAQNW
| $1.47M | ﹤0.01% |
+150,000
| New | +$139K |
|
Similar funds
Israel Englander's Q1 2020 Portfolio in Review
As of Q1 2020, Israel Englander held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander withdrew a net $20.8B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 38% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Israel Englander opened a new position in Danaher worth $133M.
- Israel Englander's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Israel Englander added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Israel Englander's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Israel Englander fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Israel Englander opened 789 new positions and closed 1,154 in Q1 2020.
- Israel Englander's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.